Tenet Healthcare (THC) Stock Declines While Market Improves: Some Information for Investors

05.06.25 00:00 Uhr

The latest trading session saw Tenet Healthcare (THC) ending at $169.89, denoting a -1.13% adjustment from its last day's close. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw a downswing of 0.22%, while the tech-heavy Nasdaq appreciated by 0.32%.Shares of the hospital operator have appreciated by 13.44% over the course of the past month, outperforming the Medical sector's loss of 2.72% and the S&P 500's gain of 5.2%.The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. The company's earnings per share (EPS) are projected to be $2.84, reflecting a 22.94% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $5.15 billion, indicating a 0.85% increase compared to the same quarter of the previous year.Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $12.69 per share and revenue of $20.9 billion. These totals would mark changes of +6.82% and +1.12%, respectively, from last year.Investors should also note any recent changes to analyst estimates for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.27% higher. As of now, Tenet Healthcare holds a Zacks Rank of #2 (Buy).In terms of valuation, Tenet Healthcare is presently being traded at a Forward P/E ratio of 13.55. This represents a premium compared to its industry's average Forward P/E of 11.65.It is also worth noting that THC currently has a PEG ratio of 1.26. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. By the end of yesterday's trading, the Medical - Hospital industry had an average PEG ratio of 1.29.The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 55, putting it in the top 23% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Quelle: Zacks

Nachrichten zu Tenet Healthcare Corp.

Wer­bung

Analysen zu Tenet Healthcare Corp.

DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
03.11.2011Tenet Healthcare overweightBarclays Capital
04.08.2011Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
03.11.2011Tenet Healthcare sector performRBC Capital Markets
21.07.2010Tenet Healthcare neutralUBS AG
02.06.2010Tenet Healthcare DowngradeRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
28.01.2009Tenet Healthcare underperformRBC Capital Markets
01.10.2008Tenet Healthcare DowngradeUBS AG
08.11.2007Tenet Healthcare underweightLehman Brothers Inc.
08.11.2007Tenet Healthcare underperformCowen and Company, LLC
11.09.2007Tenet Healthcare underweightLehman Brothers Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tenet Healthcare Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen